A preliminary trial of ascorbic acid as supplemental therapy for autism

  title={A preliminary trial of ascorbic acid as supplemental therapy for autism},
  author={Michelle C. Dolske and John J. Spollen and S McKay and E. McNamara Lancashire and Lelland C. Tolbert},
  journal={Progress in Neuro-Psychopharmacology and Biological Psychiatry},
  • M. Dolske, J. Spollen, +2 authors L. Tolbert
  • Published 1 September 1993
  • Psychology, Medicine
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry
1. This study presents the results of a 30-week double-blind, placebo-controlled trial exploring the effectiveness of ascorbic acid (8g/70kg/day) as a supplemental pharmacological treatment for autistic children in residential treatment. 2. Residential school children (N = 18) were randomly assigned to either ascorbate-ascorbate-placebo treatment order group or ascorbate-placebo-ascorbate treatment order group. Each treatment phase lasted 10 weeks and behaviors were rated weekly using the Ritvo… Expand
A Randomized Controlled Pilot Trial of Oral N-Acetylcysteine in Children with Autism
Data from this pilot investigation support the potential usefulness of NAC for treating irritability in children with autistic disorder and large randomized controlled investigations are warranted. Expand
Pilot study of a moderate dose multivitamin/mineral supplement for children with autistic spectrum disorder.
A randomized, double-blind, placebo-controlled 3-month study on the effect of a moderate dose multivitamin/mineral supplement on children with autistic spectrum disorder found that the autistic children had substantially elevated levels of B6 compared to a control group of typical children. Expand
Effect of a vitamin/mineral supplement on children and adults with autism
Oral vitamin/mineral supplementation is beneficial in improving the nutritional and metabolic status of children with autism, including improvements in methylation, glutathione, oxidative stress, sulfation, ATP, NADH, and NADPH. Expand
High-Dose Pyridoxine and Magnesium Administration in Children with Autistic Disorder: An Absence of Salutary Effects in a Double-Blind, Placebo-Controlled Study
Doubts are raised about the clinical effectiveness of HDPM in autistic disorder as assessed by the Children's Psychiatric Rating Scale (CPRS), the Clinical Global Impression Scale, and the NIMH Global Obsessive Compulsive Scale. Expand
N-Acetylcysteine as an Adjunctive Therapy to Risperidone for Treatment of Irritability in Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Efficacy and Safety
N-acetylcysteine can be considered as an adjuvant therapy for ADs with beneficial therapeutic outcomes and Repeated-measures analysis showed significant effect for time × treatment interaction in irritability and hyperactivity/noncompliance. Expand
Dietary Interventions for Autism Spectrum Disorder: A Meta-analysis
This meta-analysis does not support nonspecific dietary interventions as treatment of ASD but suggests a potential role for some specific dietary interventions in the management of some symptoms, functions, and clinical domains in patients with ASD. Expand
The effect of dietary supplements on clinical aspects of autism spectrum disorder: A systematic review of the literature
The use of dietary supplements in children with autism seems to be a safe practice with encouraging data about their clinical efficacy, and more studies are needed to further investigate this issue. Expand
Vitamin/Mineral Supplements for Children and Adults with Autism
It is recommended that all children and adults with autism consider a 2-3 month trial of a vitamin/mineral supplement designed for individuals with autism that is similar to the one used in the studies conducted by this group. Expand
Choline intervention in children with fetal alcohol spectrum disorders
The findings of the present study do not support that choline, administered at a dose of 625 mg/day for 6 weeks, is an effective intervention for children with FASD, and highlights the need for a continued understanding of the role of nutritional status and supplementation in FasD and its contributions to neurocognition. Expand
The status of pharmacotherapy for autism spectrum disorders
  • S. Myers
  • Medicine
  • Expert opinion on pharmacotherapy
  • 2007
Preliminary controlled trials of valproate, atomoxetine, α-2 adrenergic agonists and olanzapine are promising and warrant further investigation. Expand


Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms.
In this double-blind, placebo-controlled study the administration of haloperidol resulted in significant decreases in behavioral symptoms and in general clinical improvement in 40 autistic childrenExpand
Ascorbic acid and the behavioral response to haloperidol: implications for the action of antipsychotic drugs.
Results suggest that ascorbic acid plays an important role in modulating the behavioral effects of haloperidol and related antipsychotic drugs. Expand
Effect of ascorbic acid on neurochemical, behavioral, and physiological systems mediated by catecholamines.
This demonstrates the specific neurochemical, physiological, and behavioral alterations in dopaminergic systems produced by ascorbic acid and suggests possible therapeutic uses for asCorbate in conditions involving functional dopamine excess. Expand
Psychopharmacology in child and adolescent psychiatry: a review of the past five years.
A review of developments in child and adolescent psychopharmacology in the past 5 years reveals progress in the investigation of a variety of disorders and the need for classification of underlying biochemical abnormalities and additional studies of phenomenology. Expand
Ascorbic acid decreases [3H]dopamine binding in striatum without inhibiting dopamine-sensitive adenylate cyclase
Using an adenylate cyclase assay based on preparative HPLC, a failure to find inhibitory effects of ascorbate on DA-ACase occurred not only when striatal homogenates from Long-Evans rats were used, but also when tissue from Sprague-Dawley rats and Board of Health mice was tested. Expand
A scale for rating symptoms of patients with the syndrome of autism in real life settings.
A scale was developed to assess effects of treatment on 47 pathognomic behaviors in patients with the syndrome of autism. It is applicable in natural settings by nonprofessional raters who can beExpand
Ascorbate blocks amphetamine-induced turning behavior in rats with unilateral nigro-striatal lesions
Ascorbate, like other drugs blocking dopamine receptors, attenuated the amphetamine-induced turning behavior and might have a role in regulating dopaminergic transmission and could be of therapeutic value in disorders involving functional dopamine excess. Expand
Ascorbic acid and the binding of DA agonists to neostriatal membrane preparations
It is determined that sodium ascorbate was a very potent inhibitor of the specific binding of 3H-DA to a rat neostriatal membrane preparation and under conditions of these binding experiments, there was no decomposition of the 3 H-DA as determined by two separate techniques. Expand
Ascorbic acid could be hazardous to your experiments: A commentary on dopamine receptor binding studies with speculation on a role for ascorbic acid in neuronal function
Dans toute etude in vitro des catecholamines ou indoles l'acide ascorbique est automatiquement additionne a la preparation pour son effet antioxydant, ce compose pouvant jouer un role dans the fonction cerebrale normale. Expand
Modulation of neostriatal activity by iontophoresis of ascorbic acid
It is concluded that endogenous AA may modulate neuronal activity in the neostriatum by increasing the activity of some GLU-activated neurons, but suppressed the firing rate of others. Expand